BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19124064)

  • 1. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.
    Lapham A; Adams JE; Paterson A; Lee M; Brimmell M; Packham G
    Gene; 2009 Mar; 432(1-2):112-7. PubMed ID: 19124064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M; Nakamura Y; Obama K; Furukawa Y
    Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
    Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
    Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
    Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
    Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
    J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T; Rabkin SD; Martuza RL
    Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex.
    Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y
    Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
    Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.